# ANANSE: an enhancer network-based computational approach for predicting key transcription factors in cell fate determination

**Authors:** Quan Xu, Georgios Georgiou, Siebren Frölich, Maarten van der Sande, Gert Jan C Veenstra, Huiqing Zhou, Simon J van Heeringen

PMC · DOI: 10.1093/nar/gkab598 · Nucleic Acids Research · 2021-07-09

## TL;DR

ANANSE is a computational tool that identifies key transcription factors involved in cell fate determination using enhancer-based regulatory networks.

## Contribution

ANANSE introduces a novel network-based method to prioritize transcription factors using enhancer-encoded regulatory information.

## Key findings

- ANANSE outperforms existing methods in predicting key transcription factors for cell fate transitions.
- The method was applied to define an atlas of key transcription factors across 18 normal human tissues.

## Abstract

Proper cell fate determination is largely orchestrated by complex gene regulatory networks centered around transcription factors. However, experimental elucidation of key transcription factors that drive cellular identity is currently often intractable. Here, we present ANANSE (ANalysis Algorithm for Networks Specified by Enhancers), a network-based method that exploits enhancer-encoded regulatory information to identify the key transcription factors in cell fate determination. As cell type-specific transcription factors predominantly bind to enhancers, we use regulatory networks based on enhancer properties to prioritize transcription factors. First, we predict genome-wide binding profiles of transcription factors in various cell types using enhancer activity and transcription factor binding motifs. Subsequently, applying these inferred binding profiles, we construct cell type-specific gene regulatory networks, and then predict key transcription factors controlling cell fate transitions using differential networks between cell types. This method outperforms existing approaches in correctly predicting major transcription factors previously identified to be sufficient for trans-differentiation. Finally, we apply ANANSE to define an atlas of key transcription factors in 18 normal human tissues. In conclusion, we present a ready-to-implement computational tool for efficient prediction of transcription factors in cell fate determination and to study transcription factor-mediated regulatory mechanisms. ANANSE is freely available at https://github.com/vanheeringen-lab/ANANSE.

## Full-text entities

- **Genes:** NFIB (nuclear factor I B) [NCBI Gene 4781] {aka CTF, HMGIC/NFIB, MACID, NF-I/B, NF1-B, NFI-B}, PROX1 (prospero homeobox 1) [NCBI Gene 5629], TFAP2A (transcription factor AP-2 alpha) [NCBI Gene 7020] {aka AP-2, AP-2alpha, AP2TF, BOFS, TFAP2}, GATA4 (GATA binding protein 4) [NCBI Gene 2626] {aka ASD2, TACHD, TOF, VSD1}, TBX5 (T-box transcription factor 5) [NCBI Gene 6910] {aka HOS}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, Klf5 (Kruppel-like transcription factor 5) [NCBI Gene 12224] {aka 4930520J07Rik, Bteb2, CKLF, IKLF}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, Tfap2c (transcription factor AP-2, gamma) [NCBI Gene 21420] {aka AP2gamma, Ap-2.2, Stra2, Tcfap2c}, FOXA2 (forkhead box A2) [NCBI Gene 3170] {aka HNF-3-beta, HNF3B, TCF3B}, KLF4 (KLF transcription factor 4) [NCBI Gene 9314] {aka EZF, GKLF}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, NKX2-5 (NK2 homeobox 5) [NCBI Gene 1482] {aka CHNG5, CSX, CSX1, HLHS2, NKX2.5, NKX2E}, QRSL1 (glutaminyl-tRNA amidotransferase subunit QRSL1) [NCBI Gene 55278] {aka COXPD40, GatA}, ZIC2 (Zic family zinc finger 2) [NCBI Gene 7546] {aka HPE5}, NANOG (Nanog homeobox) [NCBI Gene 79923], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, Elf3 (E74-like factor 3) [NCBI Gene 13710] {aka ESE-1, ESX, jen}, KCNIP3 (potassium voltage-gated channel interacting protein 3) [NCBI Gene 30818] {aka CSEN, DREAM, KCHIP3}, SOX8 (SRY-box transcription factor 8) [NCBI Gene 30812], F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, FOXA1 (forkhead box A1) [NCBI Gene 3169] {aka HNF3A, TCF3A}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, ELF3 (E74 like ETS transcription factor 3) [NCBI Gene 1999] {aka EPR-1, ERT, ESE-1, ESX}, MEF2A (myocyte enhancer factor 2A) [NCBI Gene 4205] {aka ADCAD1, RSRFC4, RSRFC9, mef2}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, GRHL2 (grainyhead like transcription factor 2) [NCBI Gene 79977] {aka BOM, DFNA28, ECTDS, PPCD4, TFCP2L3}, PPARD (peroxisome proliferator activated receptor delta) [NCBI Gene 5467] {aka FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB}, HAND2 (heart and neural crest derivatives expressed 2) [NCBI Gene 9464] {aka DHAND2, Hed, Thing2, bHLHa26, dHand}, CTCF (CCCTC-binding factor) [NCBI Gene 10664] {aka CFAP108, FAP108, MRD21}, PAX9 (paired box 9) [NCBI Gene 5083] {aka STHAG3}, PANDAR (promoter of CDKN1A antisense DNA damage activated RNA) [NCBI Gene 101154753] {aka PANDA}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, FOXA3 (forkhead box A3) [NCBI Gene 3171] {aka FKHH3, HNF3G, TCF3G}, SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688] {aka AGM10, OF, PU.1, SFPI1, SPI-1, SPI-A}, TFAP2C (transcription factor AP-2 gamma) [NCBI Gene 7022] {aka AP2-GAMMA, ERF1, TFAP2G, hAP-2g}, GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, MYCL (MYCL proto-oncogene, bHLH transcription factor) [NCBI Gene 4610] {aka L-Myc, LMYC, MYCL1, bHLHe38}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, KLF5 (KLF transcription factor 5) [NCBI Gene 688] {aka BTEB2, CKLF, IKLF}, Tfap2a (transcription factor AP-2, alpha) [NCBI Gene 21418] {aka AP-2, AP2alpha, Ap-2 (a), Ap2, Ap2tf, Tcfap2a}, Grhl1 (grainyhead like transcription factor 1) [NCBI Gene 195733] {aka LBP-32, MGR, Tcfcp2l2}, MEF2C (myocyte enhancer factor 2C) [NCBI Gene 4208] {aka C5DELq14.3, DEL5q14.3, NEDHSIL}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, ATF5 (activating transcription factor 5) [NCBI Gene 22809] {aka ATFX, HMFN0395}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, NFIA (nuclear factor I A) [NCBI Gene 4774] {aka BRMUTD, C1DELp32p31, CTF, DEL1P32P31, NF-I/A, NF1-A}, LIN28A (lin-28 RNA binding posttranscriptional regulator A) [NCBI Gene 79727] {aka CSDD1, LIN-28, LIN28, ZCCHC1, lin-28A}
- **Diseases:** ANANSE (MESH:C564835), anchoring (MESH:C537277), palmoplantar keratoderma (MESH:D007645), desmosomal abnormalities (MESH:D000014), carcinogenesis (MESH:D063646), intestine epithelial damage (MESH:C567703)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), S3 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z233), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), HeLa-S3 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0058), hESC — Homo sapiens (Human), Embryonic stem cell (CVCL_9771), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), Hep-G2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), GM12878 — Homo sapiens (Human), Transformed cell line (CVCL_7526)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8373078/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8373078/full.md

## References

155 references — full list in the complete paper: https://tomesphere.com/paper/PMC8373078/full.md

---
Source: https://tomesphere.com/paper/PMC8373078